Doshi Dipal
CIK 0001613084
President and CEODirector
Filings
29
Latest Mar 3, 2026
Issuers covered
2
Showing
29 of 29
Page 1
Track record
20 of 20 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 20 | 70% | +5.7% | +5.6% | +25.2% | -17.9% |
| 90 days | 20 | 70% | +2.6% | +5.6% | +18.3% | -25.5% |
| 180 days | 20 | 45% | -7.2% | -3.4% | +25.1% | -42.6% |
| 365 days | 20 | 60% | +13.0% | +8.0% | +64.3% | -26.2% |
Issuers
Companies where Doshi Dipal has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | 27 | Mar 3, 2026 |
| AZTA | Azenta, Inc. | 2 | Feb 6, 2026 |
All filings
29 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|